Nuheara Balance Sheet Health

Financial Health criteria checks 3/6

Nuheara has a total shareholder equity of A$5.1M and total debt of A$2.4M, which brings its debt-to-equity ratio to 46.3%. Its total assets and total liabilities are A$13.0M and A$7.9M respectively.

Key information

46.3%

Debt to equity ratio

AU$2.37m

Debt

Interest coverage ratio	n/a
Cash	AU$2.32m
Equity	AU$5.11m
Total liabilities	AU$7.91m
Total assets	AU$13.02m

Recent financial health updates

Recent updates

Does Nuheara (ASX:NUH) Have A Healthy Balance Sheet?

Oct 09

Here's Why Nuheara (ASX:NUH) Must Use Its Cash Wisely

Jul 30

Here's Why Nuheara (ASX:NUH) Must Use Its Cash Wisely

Apr 13

We Think Nuheara (ASX:NUH) Needs To Drive Business Growth Carefully

Dec 24

Is Nuheara (ASX:NUH) In A Good Position To Deliver On Growth Plans?

Aug 25

What Can We Make Of Nuheara's (ASX:NUH) CEO Compensation?

Jan 14

Is Nuheara (ASX:NUH) Using Debt In A Risky Way?

Nov 22

Financial Position Analysis

Short Term Liabilities: NUH's short term assets (A$8.0M) exceed its short term liabilities (A$3.1M).

Long Term Liabilities: NUH's short term assets (A$8.0M) exceed its long term liabilities (A$4.8M).

Debt to Equity History and Analysis

Debt Level: NUH's net debt to equity ratio (0.9%) is considered satisfactory.

Reducing Debt: NUH's debt to equity ratio has increased from 0% to 46.3% over the past 5 years.

Balance Sheet

Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Insufficient data to determine if NUH has enough cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if NUH has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.

Discover healthy companies

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Nuheara Balance Sheet Health

Financial Health criteria checks 3/6

Key information

Recent financial health updates

Does Nuheara (ASX:NUH) Have A Healthy Balance Sheet?

Here's Why Nuheara (ASX:NUH) Must Use Its Cash Wisely

Here's Why Nuheara (ASX:NUH) Must Use Its Cash Wisely

We Think Nuheara (ASX:NUH) Needs To Drive Business Growth Carefully

Is Nuheara (ASX:NUH) In A Good Position To Deliver On Growth Plans?

Is Nuheara (ASX:NUH) Using Debt In A Risky Way?

Recent updates

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 1.850332 million.

Nuheara Limited Announces the Retirement of David Cannington as Non-Executive Director

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 3.929624 million.

New major risk - Shareholder dilution

Does Nuheara (ASX:NUH) Have A Healthy Balance Sheet?

Full year 2023 earnings released: AU$0.084 loss per share (vs AU$0.16 loss in FY 2022)

Nuheara Limited, Annual General Meeting, Nov 22, 2023

New major risk - Financial position

Nuheara Limited Announces Appointment of Catherine Morgan as Head of Compliance, Regulatory and Legal

New minor risk - Share price stability

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 4.4 million.

First half 2023 earnings released: AU$0.048 loss per share (vs AU$0.065 loss in 1H 2022)

Insufficient new directors

Nuheara Announces Commercial Availability of HP Hearing PRO OTC Hearing Aid

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 3.025401 million.

Nuheara Limited Receives US FDA Approval and Launches HP Hearing PRO

Nuheara Limited to Report Q1, 2023 Results on Oct 31, 2022

Nuheara Limited Announces the Resignation of Jean-Marie Rudd as CFO

Full year 2022 earnings released: AU$0.16 loss per share (vs AU$0.10 loss in FY 2021)

Nuheara Limited, Annual General Meeting, Nov 29, 2022

Full year 2022 earnings released: AU$0.15 loss per share (vs AU$0.093 loss in FY 2021)

Nuheara Limited Welcomes US Food and Drug Administration's Final Ruling, Establishing A Regulatory Category for Over-The-Counter (Otc) Hearing Aids in the United States

Here's Why Nuheara (ASX:NUH) Must Use Its Cash Wisely

Nuheara Limited Announces Executive Changes

Nuheara Limited has filed an IPO in the amount of AUD 5 million.

Here's Why Nuheara (ASX:NUH) Must Use Its Cash Wisely

Nuheara Submits 510(k) for U.S. FDA Clearance

Nuheara Announces Executive Changes

Nuheara Limited Announces Successful Clinical Trial Self-Fitted Hearing Aids

Nuheara Limited to Report Q2, 2022 Results on Jan 31, 2022

Nuheara Clinical Trial and FDA 510(K) Pathway Update

We Think Nuheara (ASX:NUH) Needs To Drive Business Growth Carefully

Nuheara Limited Provides Update on Clinical Trial and Pathway to FDA 510(K) Approval

Is Nuheara (ASX:NUH) In A Good Position To Deliver On Growth Plans?

Full year 2021 earnings released: AU$0.005 loss per share (vs AU$0.011 loss in FY 2020)

Nuheara Limited Receives U.S. FDA Registration and Hearing Aid Device Listing

First half 2021 earnings released: AU$0.001 loss per share (vs AU$0.006 loss in 1H 2020)

What Can We Make Of Nuheara's (ASX:NUH) CEO Compensation?

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 11.5 million.

Nuheara Limited announced that it expects to receive AUD 11.5 million in funding

Nuheara Limited Appoints Warwick Sauer as Director

Is Nuheara (ASX:NUH) Using Debt In A Risky Way?

Nuheara Receives $2 Million Phase II Works with HP Inc

Full year earnings released - AU$0.011 loss per share

Nuheara Limited announced that it has received funding

Financial Position Analysis

Debt to Equity History and Analysis

Balance Sheet

Cash Runway Analysis

Discover healthy companies